Compare ROG & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ROG | PGEN |
|---|---|---|
| Founded | 1832 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 1994 | 2013 |
| Metric | ROG | PGEN |
|---|---|---|
| Price | $140.31 | $4.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $133.00 | $8.33 |
| AVG Volume (30 Days) | 243.1K | ★ 2.8M |
| Earning Date | 04-28-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $879,091,000.00 | $230,981,000.00 |
| Revenue This Year | $7.64 | $1,115.92 |
| Revenue Next Year | $6.09 | $81.04 |
| P/E Ratio | $568.44 | ★ N/A |
| Revenue Growth | ★ 7.07 | N/A |
| 52 Week Low | $61.17 | $1.28 |
| 52 Week High | $144.46 | $5.47 |
| Indicator | ROG | PGEN |
|---|---|---|
| Relative Strength Index (RSI) | 65.77 | 58.63 |
| Support Level | $77.11 | $3.97 |
| Resistance Level | $144.46 | $5.10 |
| Average True Range (ATR) | 5.84 | 0.22 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 81.58 | 53.16 |
Rogers Corporation designs develop and manufacture engineered materials and components for sale to original equipment manufacturers and component suppliers. The firm operates in three business segments: Advanced Electronics Solutions, which manufactures circuit materials for applications in communications infrastructure, automotive, and consumer electronics markets; elastomeric material solutions, which provide cushioning, sealing, and impact protection in automotive, transportation, and construction applications; and Other, which consists of elastomer components for applications in the general industrial market, as well as elastomer floats for level sensing in fuel tanks, motors, and storage tanks applications in the general industrial and automotive markets.
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.